首站-论文投稿智能助手
典型文献
Use of angiotensin-converting enzyme inhibitors or angiotensin receptor blockers increases the risk of postoperative acute kidney injury after elective endovascular abdominal aortic aneurysm repair
文献摘要:
Background::Endovascular abdominal aortic aneurysm repair (EVAR) is the major treatment for abdominal aortic aneurysm (AAA); however, EVAR still carries a considerable risk of acute kidney injury (AKI). The present study aimed to investigate the risk factors for AKI after elective EVAR procedures.Methods::This was a retrospective observational study. Eligible patients who underwent EVAR from September 2011 to March 2019 in West China Hospital were included. The primary outcome was the occurrence of AKI within two days after EVAR, which was defined by the Kidney Disease Improving Global Outcomes Clinical Practice Guideline. Demographics, comorbidities, medications, laboratory tests, anatomical parameters of AAA, and relative operative details were collected as variables. Univariable and multivariable logistic regression analyses were applied to identify the risk factors among variables, and covariate interactions were further assessed.Results::A total of 679 eligible patients were included. The incidence of postoperative AKI was 8.2% (56/679) in the whole cohort, and it was associated with a lower 5-year survival rate (63.5% vs. 80.9%; χ2 = 4.10; P = 0.043). The multivariable logistic regression showed that chronic kidney disease (OR, 5.06; 95% CI: 1.43-17.95; P = 0.012), angiotensin-converting enzyme inhibitors (ACEIs)/angiotensin receptor blockers (ARBs) (OR, 2.60; 95% CI: 1.17-5.76; P = 0.019), and short neck (OR, 2.85; 95% CI: 1.08-7.52; P = 0.035) were independent risk factors for postoperative AKI. In the covariate interaction analysis, the effect of ACEIs/ARBs use on postoperative AKI was similar across all subgroups ( P > 0.05), thereby suggesting a robust effect of ACEIs/ARBs use in all patients undergoing elective endovascular abdominal aortic aneurysm repair. Conclusions::Postoperative AKI was associated with lower survival rate, and the use of ACEIs/ARBs was the only adjustable independent risk factor. Clinicians should consider withdrawing ACEIs/ARBs in high-risk patients undergoing elective endovascular abdominal aortic aneurysm repair to prevent postoperative AKI.
文献关键词:
Acute kidney injury;Endovascular procedures;Abdominal aortic aneurysms;Risk assessment;Angiotensin-converting enzyme inhibitors;Angiotensin receptor blockers
作者姓名:
Xiang Yuwei;Liu Yang;Zhao Jichun;Huang Bin;Wu Zhoupeng;Chen Xiyang
作者机构:
Department of Vascular Surgery, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China
引用格式:
[1]Xiang Yuwei;Liu Yang;Zhao Jichun;Huang Bin;Wu Zhoupeng;Chen Xiyang-.Use of angiotensin-converting enzyme inhibitors or angiotensin receptor blockers increases the risk of postoperative acute kidney injury after elective endovascular abdominal aortic aneurysm repair)[J].中华医学杂志(英文版),2022(23):2836-2842
A类:
Univariable
B类:
Use,angiotensin,converting,enzyme,inhibitors,receptor,blockers,increases,risk,postoperative,acute,kidney,injury,after,elective,endovascular,abdominal,aortic,repair,Background,Endovascular,EVAR,major,treatment,AAA,however,still,carries,considerable,AKI,present,study,aimed,investigate,factors,procedures,Methods,This,was,retrospective,observational,Eligible,patients,underwent,from,September,March,West,China,Hospital,were,included,primary,outcome,occurrence,within,two,days,which,defined,Kidney,Disease,Improving,Global,Outcomes,Clinical,Practice,Guideline,Demographics,comorbidities,medications,laboratory,tests,anatomical,parameters,relative,details,collected,variables,multivariable,logistic,regression,analyses,applied,identify,among,covariate,interactions,further,assessed,Results,total,eligible,incidence,whole,cohort,associated,lower,year,survival,rate,showed,that,chronic,disease,ACEIs,ARBs,short,neck,independent,In,analysis,effect,use,similar,across,all,subgroups,thereby,suggesting,robust,undergoing,Conclusions,Postoperative,only,adjustable,Clinicians,should,withdrawing,high,prevent,Acute,Abdominal,aneurysms,Risk,assessment,Angiotensin
AB值:
0.483103
相似文献
Global prevalence, mortality, and main risk factors for COVID-19 associated pneumocystosis: A systematic review and meta-analysis
Hossein Khodadadi;Ehsan Ahmadpour;Sanam Nami;Rasoul Mohammadi;Hanieh Hosseini;Mahsa Behravan;Hamid Morovati-Department of Parasitology and Mycology,School of Medicine,Shiraz University of Medical Sciences,Shiraz,Iran;Drug Applied Research Center,Tabriz University of Medical Sciences,Tabriz,Iran;Department of Medical Mycology and Parasitology,School of Medicine,Tabriz University of Medical Sciences,Tabriz,Iran;Department of Medical Parasitology and Mycology,School of Medicine,Isfahan University of Medical Sciences,Isfahan,Iran;Immunology Research Center,Tabriz University of Medical Sciences,Tabriz,Iran;Student Research Committee,Shiraz University of Medical Sciences,Shiraz,Iran
Predictors of pathologic complete response in patients with residual flat mucosal lesions after neoadjuvant chemoradiotherapy for locally advanced rectal cancer
Changlong Li;Zhen Guan;Yi Zhao;Tingting Sun;Zhongwu Li;Weihu Wang;Zhexuan Li;Lin Wang;Aiwen Wu-Key Laboratory of Carcinogenesis and Translational Research(Ministry of Education/Beijing),Gastrointestinal Cancer Center,Peking University Cancer Hospital&Institute,Beijing 100142,China;Key Laboratory of Carcinogenesis and Translational Research(Ministry of Education/Beijing),Department of Radiology,Peking University Cancer Hospital&Institute,Beijing 100142,China;Key Laboratory of Carcinogenesis and Translational Research(Ministry of Education/Beijing),Department of Pathology,Peking University Cancer Hospital&Institute,Beijing 100142,China;Key Laboratory of Carcinogenesis and Translational Research(Ministry of Education/Beijing),Department of Radiation Oncology,Peking University Cancer Hospital&Institute,Beijing 100142,China;Key Laboratory of Carcinogenesis and Translational Research(Ministry of Education/Beijing),Department of Cancer Epidemiology,Peking University Cancer Hospital&Institute,Beijing 100142,China
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。